RELieving Increasing oEdema Due to Heart Failure

Summary

This trial will investigate the potential for patiromer-facilitated use of higher doses of mineralocorticoid antagonists in addition to standard care (compared to standard care alone) to improve congestion, well-being and mortality in people who have worsening congestion due to heart failure and hyperkalaemia.

Timeline

Start

2020-08-26

Primary completion

2022-12-20

Completion

2022-12-20

Outcome

Outcome not reported

Stopped (Enrollment): “The study was stopped due to low recruitment, which the Steering Committee and funder agreed could not be rectified.”

Drugs

Indications